health
Is a new weight-loss drug making people fall out of love?
Some people using retatrutide, which is not yet approved, are reporting ‘emotional flattening’, but experts point to a more complex picture
TL;DR
- Experimental weight-loss drug retatrutide and approved GLP-1 drugs like Mounjaro are associated with reports of 'emotional flattening' and anhedonia.
- Theories suggest these drugs might dampen the brain's reward center, affecting not only food cravings but also other pleasurable experiences.
- Medical professionals note potential physical and chemical effects on libido, desire, and emotional balance, particularly in women.
- While some users report reduced desire, others experience enhanced libido due to improved confidence from weight loss.
- Experts emphasize that romantic attachment is complex and currently, the science does not definitively link these drugs to an inability to fall in love.